MCCM Tranexamicum is developed to combat hyperpigmentation, sun damage, and uneven skin tone. Formulated for use on both face and body, it works by minimizing melanin activity at the source. Ideal for clients struggling with dark spots, post-inflammatory pigmentation, or dull skin, this solution offers a gentle yet effective approach to brightening without irritation. It can be used across all skin types and is particularly recommended as part of a weekly treatment regimen to achieve consistent, visible clarity over time. How It Works Tranexamicum acid functions by stopping the synthesis of melanin at the enzyme level, where it starts. By inhibiting the conversion mechanisms that result in skin darkening, tranexamic acid, a tyrosinase inhibitor, stops excessive pigmentation. This prevents new discolouration from forming and helps lessen dark areas that already exist. Frequent use encourages treated areas to appear noticeably brighter and more evenly toned. Key Features Targeted Pigment Control: Powered by Tranexamic Acid to address both existing and future discoloration. Melanin Regulation Technology: Reduces pigment formation by inhibiting tyrosinase activity. Versatile Application: Suitable for use on both face and body, and compatible with most aesthetic protocols. Non-Aggressive Brightening: Delivers visible lightening benefits without harsh exfoliation or irritation. Professional Use Formula: Concentrated actives for weekly treatments with lasting skin tone improvement. Results Immediate: The skin feels refreshed and appears slightly more even. 2 to 4 Weeks: Visible reduction in the appearance of dark spots and uneven patches. Long-Term: Significant reduction in hyperpigmentation recurrence. Composition Aqua (Water): Hydration base for improved absorption. Mannitol: A sugar alcohol that enhances ingredient stability and skin compatibility. Tranexamic Acid: A powerful pigment-regulating agent that inhibits melanin production and improves discoloration.
Related products
